SpyGlass™ Discover Percutaneous

Completed

Conditions studied: Pancreatic Diseases, Bile Duct Obstruction, Bile Duct Diseases

In brief

To document the clinical utility of percutaneous cholangiopancreatoscopy using a thin, disposable, flexible endoscope for evaluation and treatment of complex pancreaticobiliary disease in a prospective, multi-center case series

Key facts

Study ID

NCT04580940

Run by

Boston Scientific Corporation

People needed

50

Starts

2021-07-27

Expected to finish

2023-01-14

Last updated by the study team

2023-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for a percutaneous transhepatic procedure to access the pancreaticobiliary anatomy that will accommodate passage of SpyGlass™ Discover Digital Catheter per local standard of practice
• Written informed consent from patient or legally authorized representative of the patient

You may not qualify if…

• Contraindication for cholangiopancreatoscopy
• Subjects with unresolved adverse event(s) associated with prior percutaneous pancreaticobiliary ductal access
• <18 years of age
• Potentially vulnerable subjects, including, but not limited to pregnant women

Where it is running

• Virginia Mason Medical Center — Seattle, Washington, United States
• Erasme University Hospital — Brussels, Belgium
• Toronto General Hospital, University Health Network — Toronto, Ontario, Canada
• Evangelisches Krakenhaus Düsseldorf — Düsseldorf, Germany
• Prince of Wales Hospital — Shatin, NewTerritories, Hong Kong
• Asian Institute of Gastroenterology — Hyderabad, Somajiguda, India
• Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Roma, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.